Cynata Therapeutics Limited

DB:51S Stock Report

Market Cap: €24.2m

Cynata Therapeutics Limited Company Information

Cynata Therapeutics Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Cynata Therapeutics Limited
  • Ticker: 51S
  • Exchange: DB
  • Founded: 2003
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$38.845m
  • Listing Market Cap: AU$24.242m
  • Shares Outstanding: 180.68m
  • Website: https://www.cynata.com

Location

  • Cynata Therapeutics Limited
  • 100 Cubitt Street
  • Level 3
  • Cremorne
  • Victoria
  • 3121
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CYPASX (Australian Securities Exchange)YesOrdinary SharesAUAUDDec 2007
CYPCHIA (Chi-X Australia)YesOrdinary SharesAUAUDDec 2007
CYYN.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDDec 2007
51SDB (Deutsche Boerse AG)YesOrdinary SharesDEEURDec 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 06:03
End of Day Share Price 2024/11/22 00:00
Earnings2024/06/30
Annual Earnings2024/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.